EnsembleCycPerm model accurately predicts cyclic peptide permeability by integrating solvent-dependent conformational ensembles
Background
Cyclic peptides are a promising therapeutic modality, particularly for challenging targets like protein-protein interactions. However, their clinical utility is often severely limited by inadequate membrane permeability, restricting both intracellular target access and oral bioavailability. This poor permeability arises from complex, solvent-dependent conformational ensembles, making their behavior difficult to predict. Current drug discovery efforts face significant hurdles due to the inherent structural complexity and laborious synthetic demands of these macrocycles, necessitating better predictive tools to overcome the permeability bottleneck.
Study Design
Researchers developed EnsembleCycPerm, a novel modeling framework inspired by molecular chameleons, designed to predict cyclic peptide permeability. The model integrates sequence and structural information by explicitly representing solvent-dependent conformational ensembles in both aqueous and nonpolar environments. Validation was performed using the CycPeptMPDB dataset, evaluating performance under both random split and scaffold split methodologies. The study also analyzed one-residue analog-pairs within the testing set to assess the model's ability to capture experimentally meaningful trends.
Results
The EnsembleCycPerm model demonstrated strong predictive performance for cyclic peptide permeability. Under a random split evaluation, it achieved an MAE of 0.29, a Pearson R of 0.85, and an R2 of 0.70 on the CycPeptMPDB dataset. Performance remained robust under a more challenging scaffold split evaluation, yielding an MAE of 0.34 and a Pearson R of 0.68. Beyond overall prediction, the model successfully captured experimentally meaningful ΔPAMPA trends for one-residue analog-pairs in the testing set, supporting its utility for lead optimization. Model interpretation highlighted ΔPSA3D (polarity shielding) as a key mechanistically interpretable feature strongly associated with permeability. These findings suggest that permeability emerges from ensemble reorganization rather than a single conformational transition.
The model achieved strong predictive performance with an MAE of 0.29, R of 0.85, and R2 of 0.70 on the
CycPeptMPDBunder random split evaluation.
Key Findings
- EnsembleCycPerm achieved strong predictive performance for cyclic peptide permeability (MAE = 0.29, R = 0.85, R2 = 0.70).
- Model performance remained robust under scaffold split evaluation (MAE = 0.34, Pearson R = 0.68).
- The model accurately captured experimentally meaningful
ΔPAMPAtrends for analog-pairs. - Polarity shielding, captured by
ΔPSA3D, was identified as a key feature for permeability. - Permeability is shown to emerge from
ensemble reorganizationrather than a single conformation.
Why It Matters
This new EnsembleCycPerm framework offers a significant advancement for cyclic peptide design and ADMET prediction, potentially accelerating the discovery of new therapeutics. By accurately predicting membrane permeability, it enables researchers to prioritize promising candidates earlier in the drug discovery pipeline, reducing costly experimental failures. The model's emphasis on ensemble reorganization over single conformations provides a deeper mechanistic understanding, guiding rational design strategies to optimize permeability. This could lead to more effective cyclic peptide drugs with improved oral bioavailability and intracellular target engagement, expanding their therapeutic potential beyond current limitations.
cyclic peptides
membrane permeability
computational model
drug design
admet
conformational ensemble